On this page

Meeting

COT Meeting: 7th May 2019

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday, 7th May 2019 in Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.

Last updated: 06 July 2021

View as PDF

On this page

Meeting Agenda

  1. Apologies for absence
  2. Draft minutes of March meeting TOX/MIN/2019/02
  3. Matters arising
  4. Male reproductive toxicity of a novel feed additive, 3-nitro-oxypropanol (3-NOP) (Reserved Business). TOX/2019/16
  5. Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Fusarenon-X. TOX/2019/17
  6. Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Cyclopiazonic acid (CPA). TOX/2019/18
  7. Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Patulin. TOX/2019/19
  8. Review of potential risks from 2-MCPD, 3-MCPD and glycidol and their fatty acid esters in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/20
  9. Scoping paper on the potential risks from polycyclic aromatic hydrocarbons (PAHs) in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/21
  10. Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years – Additional information on TAs. TOX/2019/22
  11. Committee statement on phosphate-based flame retardants and the potential for neurodevelopmental toxicity – second draft TOX/2019/23
  12. Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes):
  13. Toxicity assessment of flavourings used in E(N)NDS: Vanillin. TOX/2019/24
  14. Toxicity assessment of flavourings used in E(N)NDS: Cinnamaldehyde TOX/2019/25
  15. Update paper for information: FSA Scientific Advisory Committees (SACs) update. TOX/2019/26
  16. Any other business

 
Date of next meeting 2nd July 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.

Media discussed during the meeting

TOX 2019 - 17

Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Fusarenon-X

TOX 2019 - 18

Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Cyclopiazonic acid (CPA)

TOX 2019 - 19

Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Patulin

TOX 2019 - 20

Review of potential risks from 2-monochloropropanediol (MCPD), 3-MCPD and glycidol and their fatty acid esters in the diet of infants aged 0 to 12 months and children aged 1 to 5 years.

TOX 2019 - 21

Scoping paper on the potential risks from polycyclic aromatic hydrocarbons (PAHs) in the diet of infants aged 0 to 12 months and children aged 1 to 5 years

TOX 2019 - 22

Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years – additional information on tropane alkaloids (TAs)

TOX 2019 - 23

Committee statement on phosphate-based flame retardants (PFRs) and the potential for neurodevelopmental toxicity – second draft

TOX 2019 - 24

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes): Toxicity assessment of flavourings used in E(N)NDS: Vanillin

TOX 2019 - 25

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes):Toxicity assessment of flavourings used in E(N)NDS: Cinnamaldehyde

The final minutes of the meeting of the Committee held on 7th May 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.